23
Views
1
CrossRef citations to date
0
Altmetric
Review

Facial transplantation: a review of ethics, progress, and future targets

&
Pages 113-125 | Published online: 05 Sep 2011

References

  • Murray JE, Tilney NL, Wilson RE. Renal transplantation: a twenty-five year experience. Ann Surg. 1976;184(5):565–573.
  • Devauchelle B, Badet L, Lengelé B, et al. First human face allograft: early report. Lancet. 2006;368(9531):203–209.
  • Barker JH, Stamos N, Furr A, et al. Research and events leading to facial transplantation. Clin Plast Surg. 2007;34(2):233–250, ix.
  • Gordon CR, Siemionow M, Papay F, et al. The world’s experience with facial transplantation: what have we learned thus far? Ann Plast Surg. 2009;63(5):572–578.
  • Brown CS, Gander B, Cunningham M, et al. Ethical considerations in face transplantation. Int J Surg. 2007;5(5):353–364.
  • Annas GJ. Self experimentation and the Nuremberg Code. BMJ. 2010;341:c7103.
  • Salako SE. The declaration of Helsinki 2000: ethical principles and the dignity of difference. Med Law. 2006;25(2):341–354.
  • Vollmer SH, Howard G. Statistical power, the Belmont report, and the ethics of clinical trials. Sci Eng Ethics. 2010;16(4):675–691.
  • Kelly M, Butler PE. Patient selection for facial transplantation I: anatomical and surgical considerations. Int J Surg. 2004;2(2):114–115; discussion 115–116.
  • Furr LA, Wiggins O, Cunningham M, et al. Psychosocial implications of disfigurement and the future of human face transplantation. Plast Reconstr Surg. 2007;120(2):559–565.
  • Gardiner MD, Topps A, Richardson G, Sacker A, Clarke A, Butler PE. Differential judgements about disfigurement: the role of location, age and gender in decisions made by observers. J Plast Reconstr Aesthet Surg. 2010;63(1):73–77.
  • Clarke A, Butler PE. Patient selection for facial transplantation II: psychological considerations. Int J Surg. 2004;2(2):116–117 ; discussion 117–118.
  • Morris P, Bradley A, Doyal L, et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation. 2007;83(2):109–128.
  • Brill SE, Clarke A, Veale DM, Butler PE. Psychological management and body image issues in facial transplantation. Body Image. 2006;3(1): 1–15.
  • Renshaw A, Clarke A, Diver AJ, Ashcroft RE, Butler PE. Informed consent for facial transplantation. Transpl Int. 2006;19(11):861–867.
  • Butler PE, Clarke A, Ashcroft RE. Face transplantation: when and for whom? Am J Bioeth. 2004;4(3):16–17; discussion W23-W31.
  • Hurlburt M. Facial transplantation: understanding the interests of patients and hurdles to informed consent. Med Sci Monit. 2007;13(8): RA147-RA153.
  • Clarke A, Butler PE. The psychological management of facial transplantation. Expert Rev Neurother. 2009;9(7):1087–1100.
  • Morris PJ, Bradley JA, Doyal L, et al. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation. 2004;77(3):330–338.
  • Morris P, Bradley A, Doyal L, et al. Face transplantation: a review of the technical, immunological, psychological and clinical issues with recommendations for good practice. Transplantation. 2007;83(2): 109–128.
  • Johnson SE, Corsten MJ. Facial transplantation in a new era: what are the ethical implications? Curr Opin Otolaryngol Head Neck Surg. 2009;17(4):274–278.
  • Lengelé BG. Current concepts and future challenges in facial transplantation. Clin Plast Surg. 2009;36(3):507–521.
  • Thorburn G, Hettiaratchy S, Ashcroft R, Butler PE. Patient selection for facial transplantation III: ethical considerations. Int J Surg. 2004;2(2):118–119; discussion 119.
  • Clarke A, Butler PE. Facial transplantation: adding to the reconstructive options after severe facial injury and disease. Expert Opin Biol Ther. 2005;5(12):1539–1546.
  • Trachtman H. Facing the truth: a response to “On the ethics of facial transplantation research” by Wiggins, et al. Am J Bioeth. 2004;4(3): W33–W34.
  • Wiggins OP, Barker JH, Martinez S, et al. On the ethics of facial transplantation research. Am J Bioeth. 2004;4(3):1–12.
  • Sacks JM, Keith JD, Fisher C, Lee WP The surgeon’s role and responsibility in facial tissue allograft transplantation. Ann Plast Surg. 2007; 58(6):595–601.
  • Petit F, Paraskevas A, Minns AB, Lee WP, Lantieri LA. Face transplantation: where do we stand? Plast Reconstr Surg. 2004; 113(5): 1429–1433.
  • Pomahac B, Aflaki P, Nelson C, Balas B. Evaluation of appearance transfer and persistence in central face transplantation: a computer simulation analysis. J Plast Reconstr Aesthet Surg. 2010;63(5):733–738.
  • Butler PE, Clarke A, Hettiaratchy S. Facial transplantation. BMJ. 2005;331(7529):1349–1350.
  • Renshaw A, Chooneea T, Clarke A, Butler PE. An artificial prosthesis to reconstruct donor defects following facial transplantation. Clin Transplant. 2007;21(4):574–576.
  • Vasilic D, Barker JH, Blagg R, Whitaker I, Kon M, Gossman MD. Facial transplantation: an anatomic and surgical analysis of the periorbital functional unit. Plast Reconstr Surg. 2010;125(1):125–134.
  • Dubernard JM, Lengelé B, Morelon E, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357(24):2451–2460.
  • Butler PE, Hettiaratchy S, Clarke A. Managing the risks of facial transplantation. Lancet. 2006;368(9535):561–563.
  • Paradis C, Siemionow M, Papay F, et al. Ethical considerations in the first American face transplant. Plast Reconstr Surg. 2010;126(3):896–901.
  • Siemionow MZ, Papay F, Djohan R, et al. First US near-total human face transplantation: a paradigm shift for massive complex injuries. Plast Reconstr Surg. 2010;125(1):111–122.
  • Siemionow MZ, Zor F, Gordon CR. Face, upper extremity, and concomitant transplantation: potential concerns and challenges ahead. Plast Reconstr Surg. 2010;126(1):308–315.
  • Morris PJ, Bradley JA, Doyal L, et al. Facial transplantation: a working party report from the Royal College of Surgeons of England. Transplantation. 2004;77(3):330–338.
  • Majzoub RK, Cunningham M, Grossi F, Maldonado C, Banis JC, Barker JH. Investigation of risk acceptance in hand transplantation. J Hand Surg Am. 2006;31(2):295–302.
  • Dubernard JM, Owen E, Herzberg G, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353(9161):1315–1320.
  • Selvaggi G, Levi DM, Cipriani R, Sgarzani R, Pinna AD, Tzakis AG. Abdominal wall transplantation: surgical and immunologic aspects. Transplant Proc. 2009;41(2):521–522.
  • Madani H, Hettiaratchy S, Clarke A, Butler PE. Immunosuppression in an emerging field of plastic reconstructive surgery: composite tissue allotransplantation. J Plast Reconstr Aesthet Surg. 2008;61(3): 245–249.
  • Vasilic D, Alloway RR, Barker JH, et al. Risk assessment of immunosuppressive therapy in facial transplantation. Plast Reconstr Surg. 2007;120(3):657–668.
  • Chenggang Y, Yan H, Xudong Z, et al. Some issues in facial transplantation. Am J Transplant. 2008;8(10):2169–2172.
  • Baumeister S, Kleist C, Döhler B, Bickert B, Germann G, Opelz G. Risks of allogeneic hand transplantation. Microsurgery. 2004;24(2): 98–103.
  • Barker JH, Furr A, Cunningham M, et al. Investigation of risk acceptance in facial transplantation. Plast Reconstr Surg. 2006;118(3):663–670.
  • Pomahac B, Lengele B, Ridgway EB, et al. Vascular considerations in composite midfacial allotransplantation. Plast Reconstr Surg. 2010; 125(2):517–522.
  • Siemionow M, Gordon CR. Overview of guidelines for establishing a face transplant program: a work in progress. Am J Transplant. 2010; 10(5):1290–1296.
  • Chung KC, Oda T, Saddawi-Konefka D, Shauver MJ. An economic analysis of hand transplantation in the United States. Plast Reconstr Surg. 2010;125(2):589–598.
  • Toure G, Meningaud JP, Bertrand JC, Hervé C. Facial transplantation: a comprehensive review of the literature. J Oral Maxillofac Surg. 2006; 64(5):789–793.
  • McFarlane PA. Should patients remain on intensive hemodialysis rather than choosing to receive a kidney transplant? Semin Dial. 2010;23(5): 516–519.
  • Siemionow MZ, Gordon CR. Institutional review board-based recommendations for medical institutions pursuing protocol approval for facial transplantation. Plast Reconstr Surg. 2010;126(4):1232–1239.
  • Hobson JE. How the system functions. The roles of the United Network of Organ Sharing, the organ procurement and transplantation network, and the organ procurement organization in heart transplantation. Crit Care Nurs Clin North Am. 2000;12(1):11–21.
  • Thomas JM, Neville DM, Contreras JL, et al. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts. Transplantation. 1997;64(1):124–135.
  • Knechtle SJ, Vargo D, Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation. 1997; 63(1):1–6.
  • Calne R, Moffatt SD, Friend PJ, et al. Campath IH allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients. Transplantation. 1999;68(10):1613–1616.
  • Kirk AD, Hale DA, Mannon RB, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation. 2003; 76(1):120–129.
  • Kirk AD, Mannon RB, Kleiner DE, et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation. 2005;80(8): 1051–1059.
  • Farney AC, Doares W, Rogers J, et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation. 2009;88(6):810–819.
  • Kawai T, Poncelet A, Sachs DH, et al. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation. 1999;68(11):1767–1775.
  • Sharabi Y, Sachs DH. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen. J Exp Med. 1989;169(2):493–502.
  • Kawai T, Cosimi AB, Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation. 1995;59(2):256–262.
  • Kimikawa M, Sachs DH, Colvin RB, Bartholomew A, Kawai T, Cosimi AB. Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. Transplantation. 1997;64(5):709–716.
  • Helg C, Chapuis B, Bolle JF, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation. 1994;58(12):1420–1422.
  • Jacobsen N, Taaning E, Ladefoged J, Kristensen JK, Pedersen FK. Tolerance to an HLA-B, DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet. 1994;343(8900):800.
  • Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med. 1991;114(11):954–955.
  • Fudaba Y, Spitzer TR, Shaffer J, et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant. 2006;6(9): 2121–2133.
  • Mapara MY, Kim YM, Marx J, Sykes M. Donor lymphocyte infusionmediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism. Transplantation. 2003;76(2):297–305.
  • Mapara MY, Kim YM, Wang SP, Bronson R, Sachs DH, Sykes M. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood. 2002;100(5):1903–1909.
  • Kawai T, Cosimi AB, Spitzer TR, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353–361.
  • Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27(9):893–898.